The sublicensee is a Nigerian company that will manufacture in Nigeria, and the stated purpose is expansion of diagnostic manufacturing capacity in the WHO African Region.
| Record ID | TX-AFR-2025-0003 |
|---|---|
| Record type | Commercial IP transaction |
| Transaction type | Sublicence, Technology transfer, Know-how licence |
| IP rights | patent, know-how, trade secrets |
| Status | Signed |
| Qualifying date | 2025-05-09 |
| Sector | Life sciences · In-vitro diagnostics |
| African markets | Nigeria |
| Licensed territory | The announcement does not define the sublicence territory precisely; it refers to serving 'Nigeria and the region'. No country list was published in the release. |
| Disclosed value | Not disclosed in the sources reviewed. |
| Evidence | Primary source, single · 1 source(s) |
| Last verified | 2026-10-25 |
Parties
- Codix Bio (Nigeria): sublicensee
- MPP (Switzerland): sublicensor, licensor
- SD Biosensor (South Korea): licensor, rights holder
Key terms
- Interest: sublicence to develop and manufacture; Exclusivity: Not stated in source; Territorial scope: Nigeria and the region (not further defined); Field of use: Rapid diagnostic tests, initially HIV, with malaria and syphilis as further uses
Sources
- WHO and Medicines Patent Pool announce sublicensing agreement for rapid diagnostic test technology, World Health Organization / Medicines Patent Pool, 2025-05-09
Part of The Meridian’s Africa IP database. Counts, market breakdowns and rankings are derived from published records only; a record counts once. Corrections: submit evidence.
